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A plasmonic Approach to Study 
protein interaction Kinetics 
through the Dimerization of 
functionalized Ag nanoparticles
pablo A. Mercadal1, Ruben D. Motrich  2 & eduardo A. coronado1
Understanding the kinetics of protein interactions plays a key role in biology with significant 
implications for the design of analytical methods for disease monitoring and diagnosis in medical care, 
research and industrial applications. Herein, we introduce a novel plasmonic approach to study the 
binding kinetics of protein-ligand interactions following the formation of silver nanoparticles (Ag nps) 
dimers by UV-Vis spectroscopy that can be used as probes for antigen detection and quantification. 
to illustrate and test the method, the kinetics of the prototype biotin-streptavidin (Biot-StV) pair 
interaction was studied. controlled aggregates (dimers) of StV functionalized Ag nps were produced by 
adding stoichiometric quantities of gliadin-specific biotinylated antibodies (IgG-Biot). The dimerization 
kinetics was studied in a systematic way as a function of Ag NPs size and at different concentrations 
of IgG-Biot. The kinetics data have shown to be consistent with a complex reaction mechanism in 
which only the Ag NPs attached to the IgG-Biot located in a specific STV site are able to form dimers. 
These results help in elucidating a complex reaction mechanism involved in the dimerization kinetics of 
functionalized Ag nps, which can serve as probes in surface plasmon resonance-based bioassays for the 
detection and quantification of different biomarkers or analytes of interest.
The binding affinities and kinetics of protein interactions play an important role to unravel biological processes1–5. 
Moreover, bioassays based on protein interactions are routinely used for diagnosis and clinical screening in med-
ical care, research and also for biotechnology and industrial applications6,7. The methods to study protein inter-
actions can be classified as substrate based8,9 or hydrodynamics free mixing methods10,11. In the first type of 
methods, the target molecules are attached to a substrate while in the second type the molecules are mixed in a 
suitable reactor. One of the standard methods of the first category is Surface Plasmon Resonance (SPR)12,13, fre-
quently used for studying antigen-antibody interactions14,15, protein-DNA16,17 interactions and real-time analysis 
of bio-specific interactions without the use of labeled molecules8,18,19. On the same line, other methods recently 
developed include semiconductor nanowire field effect transistors, which have been applied as affinity biosensors 
able to measure protein-ligand interactions and their kinetics20–24. Typical approaches used to perform kinetic 
measurements in which both reactants are free to move are Stopped Flow25–27 and Hydrodynamic Focusing28,29. 
In the first one, large sample volumes are required making the method unsuitable for microassays. In order to 
overcome these difficulties, microfluidics techniques using hydrodynamic focusing were developed since they 
require small amounts of sample and a rapid mixing of the reactants30,31. The latter is achieved at high flow rates; 
therefore, one of the solutions must be used in excess for such a purpose30. Consequently, kinetics measurements 
that require varying the concentration of both reactants cannot be performed. Droplet based microfluidics has 
been recently introduced as an overcoming technique in which droplets can be generated into an immiscible 
carrier fluid31–33. Although the mixing process inside the droplet is not as fast as in Hydrodynamic Focusing, this 
kind of measurements has been demonstrated to be very competitive due to the low amounts of sample required 
and the precise control of the reaction and accurate monitoring of the time scale. Some notable examples in which 
this approach has been applied are the pioneering work for measuring the single turnover kinetics of ribonuclease 
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A by monitoring the steady-state fluorescence arising from the cleavage of a fluorogenic substrate34 and the more 
recent study of the STV-Biot binding via fluorescence energy transfer (FRET)32.
In the present work, we introduce a novel technique in which the reporter event is the plasmonic coupling 
between two functionalized Ag NPs and the reactants are immobilized on Ag NP surface that are free to move in 
a colloidal dispersion. The spectral feature that probes the protein interaction is the formation of Ag NP dimers 
since each interacting moiety is located on the surface of each Ag NP monomer. The formation of Ag NP dimers 
leads to a relative weak plasmon coupling due to the relative large size of the proteins involved. This feature 
is evidenced by a depletion of the extinction intensity35–37, which allows to monitor the dimerization kinetics 
in a straightforward way and therefore to account for the binding kinetics. The difference between the present 
approach and previous methodologies is that molecules that form the dimeric structures are immobilized on 
an Ag NP surface, and the kinetics process occurs in the colloidal dispersion of the functionalized Ag NPs. As 
a prototype reaction, of upmost importance in many bioassays, we study the Biot-STV interaction by induc-
ing the dimerization of STV functionalized Ag NPs through their conjugation with a biotinylated IgG antibody 
(IgG-Biot) specific for an antigen which detection/quantification may be of interest.
Results and Discussion
The controlled dimeric formation is based on the functionalization of the Ag NPs surface with Biot (HPDP) and 
STV, leaving the surface of the Ag NP modified with the Biot-STV complex. In the latter, one of the STV sites is 
bound to biotin leaving the remaining 3 sites available for interacting with any biotinylated antibody. This strategy 
of bioconjugation using a 1:1:1 Ag NPs/Biot/STV molar relation modifies the Ag NP surface with approximately 
one molecule of STV/Biot complex per NP (Fig. 1A). The formation of dimers is induced by the addition of dif-
ferent concentrations of IgG-Biot, which acts as a molecular bridge between the STV of functionalized Ag NPs 
(Fig. 1B). Spectrally, the formation of dimers is evidenced by an intensity depletion of the extinction spectra. The 
main factors that explain why the formation of dimers is evidenced as a depletion of the extinction intensity are 
the lower values of the extinction cross section of a dimer compared with the extinction cross section correspond-
ing to two monomers as well as the fact that the final concentration of NPs is smaller (note that in the limit where 
all the monomers form dimers the concentration of dimers is one half the concentration of monomers). In addi-
tion, the weak plasmonic coupling between the Ag NPs does not produce any significant change of the plasmonic 
peak position comparing the dimer and monomer spectra (Fig. S1).
Below, how the experimental decrease of the extinction intensity upon dimer formation can be used to deter-
mine the dimer concentration will be detailed. If the extinction depletion E D( ), defined as the ratio between the 





 is known, then the time dependent 








































The extinction at a given time t is given by the expression:
Figure 1. Schematic representation of the functionalization of Ag NPs and the formation of Ag NPs dimers. 
(A) Scheme of the Ag NPs functionalization with biotin-HPDP and streptavidin molecules. (B) Scheme of the 
formation of dimeric nanostructures in the presence of gliadin-specific biotinylated IgG with an interparticle 
distance of approximately 20 nm (estimated considering the geometry of the IgG antibody and the molecules 
attached to the Ag NPs).
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while the initial extinction is given by:
σ=E NPs[ ] (4)o i m
In the above equations, NPs[ ]t is the total nanoparticle concentration at time t (monomers plus dimers) while 
σm and σd are the monomer and dimer extinction cross sections, respectively.
The dimer fraction at time t can be obtained from the experimental extinction depletion and the calculated 









































































 can be calculated using the Mie theory (for any NP size and at the wavelength of the maximum), it is 
therefore a straightforward task to determine the dimer concentration during the Ag NPs dimerization process.
In order to follow the dimerization kinetics, we have performed experiments using STV functionalized Ag NPs 
of three different average diameters (36 nm, 46 nm and 76 nm) and also varying the initial IgG-Biot concentration 
for each NP size. As shown in Fig. 2 (left panels), after 30 minutes of adding different quantities of IgG-Biot for 
three different Ag NPs sizes, transmission electron microscopy (TEM) analyses revealed that the Ag nanostruc-
tures formed are mostly dimers. Morphological features indicate that the interparticle distance is approximately 
20 nm, in good agreement with the distance expected from the length of the Biot-STV-(IgG-Biot)-STV-Biot 
molecular bridge that connects the dimers. Moreover, Dynamic Light Scattering (DLS) measurements before and 
after adding the IgG-Biot to the Ag NPs colloidal dispersion qualitatively corroborated the formation of dimeric 
nanostructures (Fig. 2, right panels).
For each Ag NP size, the evolution of the extinction spectra was followed by UV-visible spectroscopy, from 
which the concentration of dimers at different times was determined using Eq. 6. Results of these experiments are 
shown in Fig. 3 for three different sizes of STV functionalized Ag NPs at five initial IgG-Biot concentrations. As 
shown, the dimer concentration increases with time until reaching an almost constant value at around 30 minutes 
(Fig. 3).
The question that then arose was how the knowledge of the time dependent dimer concentration can be 
used to obtain information about the kinetics of the STV-Biot interaction. This issue could be solved taking into 
account that the concentration of dimers at any time t is the result of a complex reaction mechanism, which in 
principle should involve all the reaction steps depicted in Table 1. In this reaction mechanism, M denotes the 
STV-functionalized Ag NPs and A the IgG-Biot antibody. Three types of STV sites able to attach to the IgG-Biot 
have been distinguished. One denoted as “central” and the other two ones denoted as “side”. In a first stage, it is 
possible that IgG-Biot binds to either the central site or to any of the side sites, yielding the MA1* and MA1 nanos-
tructures, respectively. A second antibody could also be attached to these two nanostructures giving rise to MA2* 
(if the central site has already been occupied by the first antibody or if the second antibody binds to the central 
site) or to MA2 (if both antibodies are located in the two “side” sites). These structures and the possible dimeriza-
tion reactions are depicted in Figs 4 and 5. As it will be shown later, some of the reactions are not allowed (Fig. 5).
The postulated (general) reaction mechanism was used as input to simulate the kinetics of dimer formation 
using the Kintecus software38,39. Note that the task consisted in fitting all the experimental curves of the evolution 
of the dimer (and monomer, data not shown) concentrations for a given NPs size and each initial antibody and 
NPs concentration with the same set of kinetics constants for each reaction step. Interestingly, if reactions (4) and 
(8) are allowed, it was impossible to fit the time evolution of D for all the experimental conditions (Fig. S2). This 
result is remarkable, since it shows the extreme sensibility of the time dependent dimer concentration to the spe-
cific reactions allowed in the general mechanism of dimer formation. Therefore, this kinetics modeling indicates 
that only certain configurations (marked with asterisks) in which the IgG-Biot is in the central site of STV moiety 
of the Ag NP are “active” or able to react to form dimers (Fig. 4). This site specificity seems quite reasonable since 
the other configurations shown in Fig. 5 are strongly not favored due to the steric hindrance between the location 
of the Biot moiety in the Fc region of the antibody in one NP and the relative large size of the second NP.
The set of allowed reaction rate constants for each step in this complex mechanism that are able to reproduce 
the experimental results (shown as solid lines in Fig. 3) are depicted in Table 1. All the reactions steps accounts 
essentially for the interaction between Biot and STV, and they are in the range of (70–0.4) × 107 M−1s−1. These 
rate constants are in excellent agreement with previously reported data20,32. However, there are some important 
differences and similarities between the rate constants obtained in the present work that deserve to be highlighted 
and compared with recent works where the STV-Biot binding kinetics was measured in real time. Using a droplet 
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microfluidics approach32, Srisa-Art et al. reported that the STV-Biot interaction is biphasic due to the multiple 
Biot binding sites on a STV molecule, with rate constants values of 4.5 × 107 M−1s−1 and 3.6 × 106 M−1s−1 associ-
ated to two different binding processes. The lowest value was explained in terms of the steric hindrance produced 
Figure 2. Transmission Electron Microscopy images and Dynamic Light Scattering response of the Ag 
nanostructures formed 30 minutes after adding different gliadin-specific biotinylated IgG concentrations.  
(A) TEM images of 38 nm diameter Ag NPs/0.75 ng/mL IgG-Biot and DLS analysis plot of the isolated Ag NPs. 
(B) TEM image of 46 nm diameter Ag NPs/0.5 ng/mL IgG-Biot and DLS analysis plot of the isolated Ag NPs. 
(C) TEM image of 76 nm Ag NPs/0.25 ng/mL IgG-Biot and DLS analysis plot of the isolated Ag NPs.  
Red squares show image magnifications of the Ag nanostructures formed 30 minutes after adding IgG-Biot.
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by the first Biot binding site since the biotin molecule was attached to a DNA strand. The kinetics data of the 
present work can be perfectly explained considering the same arguments. Comparing the rate constants of reac-
tions (1), (5) and (10), the general trend is that the rate constant decreases as the successive sites of STV are being 
occupied by biotinylated antibodies, in an analogous way as previously observed by Srisa-Art et al.32. However 
and noteworthy, this effect seems to be less pronounced in the present work.
The steric hindrance effect on the STV-Biot rate constant can be appreciated more clearly when this inter-
action gives rise to Ag NP dimers. The rate constants for the dimerization process exhibit a significant decrease 
Figure 3. Experimental (squared symbols) and kinetics modelling (solid lines) of the evolution of the dimer 
concentration for different Ag NPs sizes and initial biotinylated IgG (IgG-Biot) concentrations. (A) 38 nm 
diameter Ag NPs, (B) 46 nm diameter Ag NPs, (C) 76 nm diameter Ag NPs. The initial IgG-Biot concentrations 




Ag NPs 38 nm
k(M−1 s−1)
Ag NPs 46 nm
k(M−1 s−1)
Ag NPs 76 nm
(1) M + A → MA1* (6 ± 2) × 107 (5 ± 3) × 107 (6 ± 4) × 107
(2) M + A → MA1 (4 ± 1) × 107 (3 ± 2) × 107 (5 ± 3) × 107
(3) MA1* + M → D (5 ± 3) × 108 (7 ± 4) × 108 (4 ± 3) × 108
(4) MA1 + M → D not allowed not allowed not allowed
(5) MA1* + A → MA2* (4 ± 1) × 107 (4 ± 3) × 107 (3 ± 1) × 107
(6) MA1 + A → MA2* (6 ± 2) × 107 (4 ± 3) × 107 (5 ± 4) × 107
(7) MA1 + A → MA2 (2 ± 1) × 107 (3 ± 1) × 107 (3 ± 2) × 107
(8) MA2 + M → D not allowed not allowed not allowed
(9) MA2* + M → D (4 ± 2) × 108 (5 ± 1) × 108 (4 ± 3) × 108
(10)MA2* + A → MA3* (3 ± 2) × 107 (1 ± 0.5) × 107 (1 ± 0.4) × 107
(11) MA2 + A → MA3* (5 ± 1) × 107 (1 ± 0.5) × 107 (2 ± 1) × 107
(12) MA3* + M → D (1 ± 0.6) × 107 (1 ± 0.5) × 107 (2 ± 1) × 107
Table 1. Rate constants for each step of the site specific mechanism between STV functionalized Ag NPs (M) 
and biotinylated Ig-G antibodies (A). *Species with a biotinylated IgG (IgG-Biot) in the binding reactive site of 
STV.
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from values around 4–7 × 108 to 1–2 × 107 M−1s−1 comparing reactions (3) and (12) of Table 1. In reaction (3), 
the Ag NP is already bound to only one activated biotinylated antibody, while in reaction (12) the Ag NP is bound 
to three IgG-Biot antibodies, making the central active site less available and therefore leading to a smaller rate 
constant. An important arising fact is that the overall rate constants for reactions (3) and (9) are almost one order 
of magnitude greater than reaction (1) and (5) (which involves reactions between STV functionalized Ag NPs 
and IgG-Biot). These differences can be rationalized by comparing the rate constant obtained by microfluidics 
approaches32 with the affinity constant obtained using silicon nanowire biosensors20. In the first case, Biot and 
STV molecules are kept in a colloidal dispersion while in the second one Biot is bound to the surface of a sili-
con nanowire field effect transistor and STV is allowed to attach to this surface from an analyte solution. The 
highest values reported for the rate constants using the above mentioned methodologies20,32 are 4.5 × 107 and 
5.5 × 108 M−1s−1, which also have an order of magnitude of difference, and similar to the results obtained in the 
present work for reactions (3) and (9). One possible explanation is that the probability of binding between STV 
and Biot not only depends on the steric hindrance but also on the freedom to move of both moieties (STV-Biot) 
in the system. If both entities are free to rotate, the number of events leading to a successful binding is lower 
with respect to the process in which one of the reactants is attached to a surface. To the best of our knowledge, 
this important effect (concerning molecular freedom) has not been addressed before in the kinetics of Biot-STV 
protein interaction.
Finally, another aspect that worth to be highlighted is the excellent agreement between the obtained experi-
mental and simulated values for all the conditions shown in Fig. 3. That reflects the validity of the used kinetics 
modelling that further supports our conclusions.
The presented core conclusions as the role played by the steric hindrance in the incorporation of a second 
IgG-Biot as well as that the magnitude of the kinetic rate constant depends on the degree of mobility of the 
reactants provides a better understanding about protein interactions in nanostructures. The features highlighted 
above are of paramount importance for the development of new therapeutic protocols since they give information 
Figure 4. Representative scheme of the involved structures that lead to dimer formation in the proposed 
reaction mechanism for the interaction of gliadin-specific biotinylated IgG (IgG-Biot) functionalized Ag NPs 
with the reactive site of a STV functionalized Ag NPs.
Figure 5. Representative scheme of the structures that are not allowed to form dimers in the proposed reaction 
mechanism for the interaction of gliadin-specific biotinylated IgG (IgG-Biot) functionalized Ag NPs with the 
STV functionalized Ag NPs.
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about the time-scale necessary to perform bioassays as well as the reaction mechanism involved. Furthermore, 
they could help for the design of robust, sensitive, and inexpensive methods for the detection of different biomark-
ers for disease monitoring and diagnosis in medical care, or other proteins of interest for research or industrial 
applications6–12. In this regard, some SPR based methods using metal NPs have been recently developed7,10–17,33–35. 
Among them, the intensity depletion immune-linked assay (IDILA) has been shown to be a promising alternative 
method for the inexpensive, rapid, accurate and ultrasensitive detection of disease biomarkers or food antigens in 
real samples33–35. This new sensing platform employs probes which consist in Biot-STV functionalized plasmonic 
Ag NPs linked to biotinylated antibodies specific to the protein/analyte of interest. Herein, we provide evidence 
that elucidates the molecular interactions involved in the functionalization of the Ag NPs with the specific anti-
body used as a probe in these bioassays.
One example where the present approach could be useful is for the development of methods to quantify anti-
gens and antibodies. In this regard, it has been recently reported the synthesis of asymmetrically functionalized 
antibody-metal nanoparticles, with the aim to overcome the limitations of aggregation-based conjugates based 
immunoassays. These asymmetric conjugates assembled into dimers with the addition of antigen. The present 
methodology applied to this dimerization process should be able to elucidate the relevant kinetics information for 
the design of an immunoassay able to quantify antigens at very small concentrations, improving the performance 
of other aggregation-based immunoassays40–44.
concluding Remarks
In summary, in the present work we provided the kinetic parameters and elucidated a complex reaction mecha-
nism that involves the ubiquitous Biot-STV interaction based on the dimerization kinetics of functionalized Ag 
NPs, which can serve as probes in SPR-based methods for the detection and quantification of different protein 
analytes. The relative large interparticle distance of the dimers produce an intensity depletion of the extinction 
spectra with respect to the isolated functionalized Ag NPs. This unique dimeric structure has an extinction cross 
section that peaks at almost the same wavelength of the monomer, with a value that is greater than the extinction 
cross section of two monomers, but less than twice. The above mentioned feature, together with the fact that the 
global nanostructure concentration (dimers plus monomers) decreases during the dimerization process, give rise 
to only a depletion of the peak extinction intensity.
From the extinction depletion as well as the initial NP concentration and the cross sections of the monomers 
and dimers, the evolution of D[ ] can be easily obtained for any set of initial conditions. This information can be 
modelled with kinetics software by postulating a reaction mechanism, from which the reaction rate constants for 
the different steps involving protein interactions can be obtained. This novel strategy has been applied for study-
ing the interactions of STV with a biotinylated antibody, both reactants immobilized on an Ag NP surface. It was 
found that only certain configurations of the IgG-Biot functionalized Ag NPs leads to the formations of dimers, 
i.e. only those where the antibody is located in a “central” or active site of STV. The rate constants obtained are in 
excellent agreement with previously reported data and lead to three important features concerning protein 
interactions:
 (a) The role played by the steric hindrance in the incorporation of a second IgG-Biot to an already functional-
ized Ag NP with one antibody.
 (b) The site specificity of the dimerization process.
 (c) The fact that the magnitude of the kinetic rate constant depends on the degree of mobility of the reactants. 
This issue explains why the k values for NP dimerization are almost an order of magnitude grater (~10) 
than those corresponding to the reaction of a free IgG-Biot with a STV functionalized Ag NP. In the first 
process, both STV and the antibody are fixed to the NP surface and have less freedom to move, while in the 
second one only STV is fixed to the Ag NP.
These results are consistent with previous rate constants determined for STV-Biot interactions, but have not 
been highlighted before.
We anticipate that the present plasmonic approach based on the dimerization of functionalized Ag NPs could 
be a very versatile, simple and straightforward methodology to study protein interactions by optical means. 
Moreover, the present procedure can be adequately modified to study many relevant antigen-antibody inter-
actions, which are of outmost importance to foster current understanding of many processes in cell biology, to 
improve drug discovery testing methods and affinity biodetection sensors for disease monitoring and diagnosis 
in medical care, research and industrial applications.
Methods
Reagents. The following reagents were used: AgNO3 (Blaker - Sigma Aldrich, St. Louis, MO, USA), sodium 
citrate (Anedra, Buenos Aires, Argentina), EZ-Link Biotin-HPDP (Pierce Biotechnology, Thermo Fisher, 
Rockford, IL, USA), streptavidin (Invitrogen, Carlsbad, CA, USA), biotinylated IgG antibody specific to wheat 
gliadin (LSBio Inc., Seattle, WA, USA), phosphate buffer solution, polysorbate 20 (Tween 20) (Sigma Aldrich), 
diluent solution [PBS containing 1% bovine serum albumin (BSA), Sigma Aldrich].
Synthesis and functionalization of the Ag nanoparticles in colloidal dispersion. The synthesis of 
different Ag NPs size was performed by the Turkevich’s method45 adding 2.5, 1.75 or 1 mL of 0.01 M sodium cit-
rate and 1 mL of 0.01 M Silver Nitrate solutions to 150 ml of boiling water under magnetic stirring. After 30 min, 
when a yellowish or yellow-white colour was observed the reaction was stopped. Silver NPs of average diameters 
of 36, 48, and 76 nm were obtained (Fig. S3). Using the Mie’s theory (to obtain the corresponding theoretical 
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extinction cross sections (σExt)46 of diferent Ag NPs size) together with the Beer’s law, the following molar con-
centrations were obtained: 8.30 × 10−12 M, 3.58 × 10−12 M and 1.09 × 10−12 M for the 36, 46 and 76 nm Ag NPs 
average diameter colloidal dispersions, respectively.
For the surface modification of Ag NPs with streptavidin and Biotin-HPDP, Ag NPs of the three different sizes 
were incubated with STV/Biot in a 1: 1: 1 molar ratio (Ag NP-STV-Biot) for 1 hour at room temperature (Fig. S4).
Extinction measurements. The optical characterization of Ag NPs was performed by UV-visible spec-
troscopy scanning in the 300–1100 nm wavelength range. The spectra obtained were measured using a Shimazdu 
UV-1700 PharmaSpec spectrophotometer (Shimadzu, Kyoto, Japan) with a 1 cm quartz cell at room temperature.
transmission electron microscopy. The morphological characterization of Ag NPs was performed by 
TEM using a JEM-JEOL 1120 EXII transmission electronic microscope (JEOL Ltd., Boston, MA, USA) under 
an accelerating voltage of 80 kV. Samples were prepared by adding one drop (∼30 μL) of the colloidal solution 
samples onto a holey carbon-formvar coated copper TEM grid (100 mesh).
Dynamic light scattering. The characterization of the Ag NPs colloidal dispersion was also performed by 
DLS using a Delsa Nano 2.2 spectrophotometer (Beckman Coulter Inc., Brea, CA, USA) with a cell of 1 cm quartz 
at room temperature.
computational methods. The extinction spectra of isolated Ag NPs was simulated using the Mie’s theory 
and the dimeric nanostructures using the Mie’s theory generalized for multiple-particles (GMM)35,46. In all calcu-
lations performed, the NPs were excited by a plane wave with an incidence pointing vector (propagation direc-
tion) normal to the surface. All the extinction spectra of Ag NPs dimers were calculated using an interparticle 
spacing (gap distance) of 20 nm. The average extinction cross section was obtained by averaging the extinction 
cross sections that result from illuminating the dimer with polarizations around the x, y and z. 







. In all the simulations, the dielectric function tabulated by Palik47 for Ag was used. For 
the simulations of the extinction spectra of Ag NP monomers, the dielectric constant of the medium was of 1.77, 
corresponding to water, while for Ag NPs dimers a value of 1.87 was considered suitable due to the change pro-
duced by the addition of 1% BSA-PBS for the stabilization of the added antibody. The calculated extinction cross 
sections (σext) values for isolated Ag NPs with 38, 46 and 76 nm average diameters are 1.36 × 10−10 cm2, 
1.87 × 10−10 cm2, and 4.40 × 10−10 cm2, respectively; while the σext for the respective dimers are 2.11 × 10−10 cm2, 
2.84 × 10−10 cm2 and 7.14 × 10−10 cm2. All of these extinction cross sections were calculated at the wavelength 
corresponding to the maximum for each spectrum.
Kinetic modelling. The kinetic modeling was performed using the Kintecus software38. The optimization of 
reaction mechanism was determined using, as input, the time evolution of both Ag NPs dimers as well as Ag NPs 
monomers for different IgG-Biot and Ag NPs initial concentrations. Different possible reaction mechanisms were 
explored, as detailed, and the rate equations were integrated using a time step of 10−6 s.
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